Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study.

The publication “Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study.” is organized in H2HUBB under the research focus hydrogen inhalation cancer supportive study 2020. The publication is cited as Chen JB, Kong XF, Qian W, Mu F, Lu TY, Lu YY, Xu KC, Medical gas research, 2020. This uncontrolled human study examined Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study. The abstract describes Human participants; hydrogen delivered as hydrogen inhalation; reported duration 4 hours. This is an automated editorial draft based on the abstract and requires source review before publication.

Hydrogen inhalation cancer supportive study 2020 overview

For patients with advanced non-small cell lung cancer, we report here on two objectives, the immunosenescence for advanced non-small cell lung cancer and hydrogen… Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.

Study design and hydrogen intervention

Publication type: Uncontrolled human study. Evidence type: Human clinical evidence. Research model or population: Human participants. Blinding: Unknown. Control status: Control group reported.

Delivery method: Hydrogen inhalation. Hydrogen flow rate: 3 L/min. Dose or treatment amount: 3 L. Treatment duration: 4 hours.

Reported findings and scientific interpretation

For this hydrogen inhalation cancer supportive study 2020, the study record reports the following: No detailed finding statement was available for this record. Readers should consult the original publication before drawing conclusions.

These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.

How this research record was prepared

H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.

Limitations, safety, and original source

Limitations: The intervention or follow-up period appears relatively short.

Safety: The abstract did not provide detailed safety or adverse-event information.

This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.